Zuber Lawler: Schedule III Cannabis: FDA’s New Frontier
Schedule III Cannabis: FDA’s New Frontier Schedule III Cannabis: FDA’s New Frontier Article by: Raza Lawrence and Ivy Perez-Bader Federal cannabis rescheduling has been widely discussed as a tax, banking, and criminal-law inflection point. Far less attention has been...
Seyfarth: Marijuana Rescheduling: Should Employers Update Their Drug Testing Policies and Practices?
Marijuana Rescheduling: Should Employers Update Their Drug Testing Policies and Practices? By Seyfarth Shaw LLP on January 26, 2026 By: Adam R. Young, Jennifer L. Mora, and Frederick T. Smith Seyfarth Synopsis: President Trump’s December 2025 Executive Order signals a...
FrantzWard: Jim Ickes Examines Growing Federal Conflict Over State Cannabis Markets (23 January 2026)
Jim Ickes Examines Growing Federal Conflict Over State Cannabis Markets (23 January 2026) Despite the rapid expansion of state-legal cannabis markets, the constitutional limits on how states may regulate those markets remain unsettled. One of the most...
McDermott Will & Schulte: Rolling forward: Cannabis reform takes a new turn (22 January 2026)
Rolling forward: Cannabis reform takes a new turn (22 January 2026) Federal cannabis policy is entering a new phase. The Trump administration’s executive order to reclassify marijuana under the Controlled Substances Act (CSA) marks a historic shift with broad...
Buchanan: Legalization and Regulatory Framework for Adult-Use Marijuana
Legalization and Regulatory Framework for Adult-Use Marijuana On the heels of the election of Governor Abigail Spanberger, who has publicly supported the legalization and sale of adult-use marijuana, Delegate Paul Krizek introduced HB624 on January 14, 2026. The bill...Top 200 Cannabis Lawyers
We Support